期刊
ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 8, 期 5, 页码 1763-1790出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.2c00026
关键词
dexamethasone; drug delivery; drug repurposing; nanomaterials; tissue engineering
Dexamethasone (DEX) is widely used to treat various diseases, but its poor solubility limits its clinical usage. Efficient DEX-loaded nanoformulations have been developed to mitigate its side effects and promote scientific research. Various nanoparticles have been used to selectively deliver drugs without damaging healthy cells or organs.
Dexamethasone (DEX) has been widely used to treat a variety of diseases, including autoimmune diseases, allergies, ocular disorders, cancer, and, more recently, COVID-19. However, DEX usage is often restricted in the clinic due to its poor water solubility. When administered through a systemic route, it can elicit severe side effects, such as hypertension, peptic ulcers, hyperglycemia, and hydro-electrolytic disorders. There is currently much interest in developing efficient DEX-loaded nanoformulations that ameliorate adverse disease effects inhibiting advancements in scientific research. Various nanoparticles have been developed to selectively deliver drugs without destroying healthy cells or organs in recent years. In the present review, we have summarized some of the most attractive applications of DEX-loaded delivery systems, including liposomes, polymers, hydrogels, nanofibers, silica, calcium phosphate, and hydroxyapatite. This review provides our readers with a broad spectrum of nanomedicine approaches to deliver DEX safely
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据